Intellia Therapeutics Inc 2022 SR
The report outlines Intellia Therapeutics' commitment to patients, employees, the environment, and corporate governance. Key highlights include dosing over 50 patients in clinical trials for CRISPR-based therapies and achieving human proof-of-concept in three clinical programs. The company emphasizes its focus on diversity, equity, and inclusion, reporting that 56% of its workforce is female and launching new Employee Resource Groups in 2022. Additionally, Intellia highlights its efforts in cybersecurity, community engagement through STEM initiatives, and alignment with SASB reporting standards for the biotechnology and pharmaceuticals industry.
Company: Intellia Therapeutics Inc
Sector: Professional & technical services
Country: United States
Year: 2022
Type: SR
Pages: 44
Back to company
Intellia Therapeutics Inc
Corporate Responsibility Report
The report outlines Intellia Therapeutics' commitment to patients, employees, the environment, and corporate governance. Key highlights include dosing over 50 patients in clinical trials for CRISPR-based therapies and achieving human proof-of-concept in three clinical programs. The company emphasizes its focus on diversity, equity, and inclusion, reporting that 56% of its workforce is female and launching new Employee Resource Groups in 2022. Additionally, Intellia highlights its efforts in cybersecurity, community engagement through STEM initiatives, and alignment with SASB reporting standards for the biotechnology and pharmaceuticals industry.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
2022
Fiscal Year
2022
Published
May 1, 2023
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women on Board
Women in Management
Employees